Opus Genetics Stock Forecast - Naive Prediction
| IRD Stock | 2.50 0.14 5.93% |
The Naive Prediction forecasted value of Opus Genetics on the next trading day is expected to be 2.80 with a mean absolute deviation of 0.09 and the sum of the absolute errors of 5.88. Opus Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Opus Genetics stock prices and determine the direction of Opus Genetics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Opus Genetics' historical fundamentals, such as revenue growth or operating cash flow patterns.
The relative strength index (RSI) of Opus Genetics' stock price is about 61. This usually indicates that the stock is rather overbought by investors at the present time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Opus, making its price go up or down. Momentum 61
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.10) | EPS Estimate Current Year (0.62) | EPS Estimate Next Year (0.43) | Wall Street Target Price 7.7273 | EPS Estimate Current Quarter (0.13) |
Using Opus Genetics hype-based prediction, you can estimate the value of Opus Genetics from the perspective of Opus Genetics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Opus Genetics using Opus Genetics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Opus using crowd psychology based on the activity and movement of Opus Genetics' stock price.
Opus Genetics Short Interest
A significant increase or decrease in Opus Genetics' short interest from the previous month could be a good indicator of investor sentiment towards Opus. Short interest can provide insight into the potential direction of Opus Genetics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 1.4509 | Short Percent 0.011 | Short Ratio 1.39 | Shares Short Prior Month 635.9 K | 50 Day MA 2.063 |
Opus Genetics Hype to Price Pattern
Investor biases related to Opus Genetics' public news can be used to forecast risks associated with an investment in Opus. The trend in average sentiment can be used to explain how an investor holding Opus can time the market purely based on public headlines and social activities around Opus Genetics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Opus Genetics Implied Volatility | 0.9 |
Opus Genetics' implied volatility exposes the market's sentiment of Opus Genetics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Opus Genetics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Opus Genetics stock will not fluctuate a lot when Opus Genetics' options are near their expiration.
The Naive Prediction forecasted value of Opus Genetics on the next trading day is expected to be 2.80 with a mean absolute deviation of 0.09 and the sum of the absolute errors of 5.88. Opus Genetics after-hype prediction price | USD 2.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Opus Genetics to cross-verify your projections. Open Interest Against 2026-03-20 Opus Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Opus Genetics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Opus Genetics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Opus Genetics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Opus Genetics' open interest, investors have to compare it to Opus Genetics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Opus Genetics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Opus. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Opus Genetics Additional Predictive Modules
Most predictive techniques to examine Opus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Opus using various technical indicators. When you analyze Opus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Opus Genetics Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Opus Genetics' financial statements to predict how it will affect future prices.
Cash | First Reported 2020-12-31 | Previous Quarter 32.4 M | Current Value 30.8 M | Quarterly Volatility 12 M |
Opus Genetics Naive Prediction Price Forecast For the 24th of January
Given 90 days horizon, the Naive Prediction forecasted value of Opus Genetics on the next trading day is expected to be 2.80 with a mean absolute deviation of 0.09, mean absolute percentage error of 0.01, and the sum of the absolute errors of 5.88.Please note that although there have been many attempts to predict Opus Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Opus Genetics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Opus Genetics Stock Forecast Pattern
| Backtest Opus Genetics | Opus Genetics Price Prediction | Buy or Sell Advice |
Opus Genetics Forecasted Value
In the context of forecasting Opus Genetics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Opus Genetics' downside and upside margins for the forecasting period are 0.03 and 7.28, respectively. We have considered Opus Genetics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Opus Genetics stock data series using in forecasting. Note that when a statistical model is used to represent Opus Genetics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.6646 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0948 |
| MAPE | Mean absolute percentage error | 0.045 |
| SAE | Sum of the absolute errors | 5.8787 |
Predictive Modules for Opus Genetics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Opus Genetics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Opus Genetics After-Hype Price Prediction Density Analysis
As far as predicting the price of Opus Genetics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Opus Genetics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Opus Genetics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Opus Genetics Estimiated After-Hype Price Volatility
In the context of predicting Opus Genetics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Opus Genetics' historical news coverage. Opus Genetics' after-hype downside and upside margins for the prediction period are 0.13 and 6.94, respectively. We have considered Opus Genetics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Opus Genetics is very risky at this time. Analysis and calculation of next after-hype price of Opus Genetics is based on 3 months time horizon.
Opus Genetics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Opus Genetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Opus Genetics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Opus Genetics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 4.48 | 0.03 | 0.36 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.50 | 2.50 | 0.00 |
|
Opus Genetics Hype Timeline
On the 23rd of January Opus Genetics is traded for 2.50. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of -0.36. Opus is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.47%. %. The volatility of related hype on Opus Genetics is about 578.81%, with the expected price after the next announcement by competition of 2.14. About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.86. Opus Genetics last dividend was issued on the 6th of November 2020. The entity had 1:4 split on the 6th of November 2020. Considering the 90-day investment horizon the next projected press release will be in about 10 days. Check out Historical Fundamental Analysis of Opus Genetics to cross-verify your projections.Opus Genetics Related Hype Analysis
Having access to credible news sources related to Opus Genetics' direct competition is more important than ever and may enhance your ability to predict Opus Genetics' future price movements. Getting to know how Opus Genetics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Opus Genetics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ABOS | Acumen Pharmaceuticals | 0.23 | 3 per month | 0.00 | (0.04) | 9.18 | (7.18) | 25.06 | |
| SEER | Seer Inc | (0.31) | 37 per month | 0.00 | (0.13) | 3.41 | (3.06) | 9.98 | |
| AGEN | Agenus Inc | (0.04) | 6 per month | 0.00 | (0.04) | 7.76 | (6.05) | 35.29 | |
| INO | Inovio Pharmaceuticals | 0.23 | 6 per month | 0.00 | (0.11) | 6.87 | (6.80) | 36.52 | |
| VTGN | VistaGen Therapeutics | (0.01) | 6 per month | 0.00 | (0.12) | 7.93 | (12.80) | 96.59 | |
| HURA | TuHURA Biosciences | (0.05) | 12 per month | 0.00 | (0.24) | 7.73 | (10.53) | 50.34 | |
| ALEC | Alector | 0.23 | 3 per month | 0.00 | (0.07) | 5.63 | (8.33) | 58.73 | |
| CGTX | Cognition Therapeutics | (0.23) | 3 per month | 0.00 | (0.05) | 8.89 | (8.38) | 24.96 | |
| TIL | Instil Bio | 0.49 | 9 per month | 0.00 | (0.18) | 6.59 | (9.97) | 55.58 | |
| MCRB | Seres Therapeutics | (8.28) | 8 per month | 0.00 | (0.03) | 9.13 | (7.64) | 54.10 |
Other Forecasting Options for Opus Genetics
For every potential investor in Opus, whether a beginner or expert, Opus Genetics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Opus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Opus. Basic forecasting techniques help filter out the noise by identifying Opus Genetics' price trends.Opus Genetics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Opus Genetics stock to make a market-neutral strategy. Peer analysis of Opus Genetics could also be used in its relative valuation, which is a method of valuing Opus Genetics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Opus Genetics Market Strength Events
Market strength indicators help investors to evaluate how Opus Genetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Opus Genetics shares will generate the highest return on investment. By undertsting and applying Opus Genetics stock market strength indicators, traders can identify Opus Genetics entry and exit signals to maximize returns.
Opus Genetics Risk Indicators
The analysis of Opus Genetics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Opus Genetics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting opus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.32 | |||
| Semi Deviation | 3.51 | |||
| Standard Deviation | 4.35 | |||
| Variance | 18.92 | |||
| Downside Variance | 15.03 | |||
| Semi Variance | 12.29 | |||
| Expected Short fall | (3.75) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Opus Genetics
The number of cover stories for Opus Genetics depends on current market conditions and Opus Genetics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Opus Genetics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Opus Genetics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Opus Genetics Short Properties
Opus Genetics' future price predictability will typically decrease when Opus Genetics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Opus Genetics often depends not only on the future outlook of the potential Opus Genetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Opus Genetics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.7 M | |
| Cash And Short Term Investments | 30.3 M |
Check out Historical Fundamental Analysis of Opus Genetics to cross-verify your projections. For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opus Genetics. If investors know Opus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opus Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.86) | Revenue Per Share | Quarterly Revenue Growth (0.20) | Return On Assets | Return On Equity |
The market value of Opus Genetics is measured differently than its book value, which is the value of Opus that is recorded on the company's balance sheet. Investors also form their own opinion of Opus Genetics' value that differs from its market value or its book value, called intrinsic value, which is Opus Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opus Genetics' market value can be influenced by many factors that don't directly affect Opus Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opus Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Opus Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opus Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.